These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

674 related articles for article (PubMed ID: 17482778)

  • 21. Physicochemical characterization and in vitro release studies of ascorbyl palmitate-loaded semi-solid nanostructured lipid carriers (NLC gels).
    Teeranachaideekul V; Souto EB; Müller RH; Junyaprasert VB
    J Microencapsul; 2008 Mar; 25(2):111-20. PubMed ID: 18246489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of lycopene-loaded nanostructured lipid carriers: effect of rice oil and cholesterol.
    Riangjanapatee P; Müller RH; Keck CM; Okonogi S
    Pharmazie; 2013 Sep; 68(9):723-31. PubMed ID: 24147340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stabilization of all-trans retinol by loading lipophilic antioxidants in solid lipid nanoparticles.
    Jee JP; Lim SJ; Park JS; Kim CK
    Eur J Pharm Biopharm; 2006 Jun; 63(2):134-9. PubMed ID: 16527470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system.
    Hu FQ; Jiang SP; Du YZ; Yuan H; Ye YQ; Zeng S
    Colloids Surf B Biointerfaces; 2005 Nov; 45(3-4):167-73. PubMed ID: 16198092
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid nanocarriers for dermal delivery of lutein: preparation, characterization, stability and performance.
    Mitri K; Shegokar R; Gohla S; Anselmi C; Müller RH
    Int J Pharm; 2011 Jul; 414(1-2):267-75. PubMed ID: 21596122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and ocular tolerance of flurbiprofen loaded ultrasound-engineered NLC.
    Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Colloids Surf B Biointerfaces; 2010 Dec; 81(2):412-21. PubMed ID: 20719479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of surfactant on lycopene-loaded nanostructured lipid carriers.
    Riangjanapatee P; Okonogi S
    Drug Discov Ther; 2012 Jun; 6(3):163-8. PubMed ID: 22890207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Physicochemical characterization of lycopene-loaded nanostructured lipid carrier formulations for topical administration.
    Okonogi S; Riangjanapatee P
    Int J Pharm; 2015 Jan; 478(2):726-35. PubMed ID: 25479097
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
    Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY
    Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
    Das S; Ng WK; Tan RB
    Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
    Huang ZR; Hua SC; Yang YL; Fang JY
    Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC).
    Fang JY; Fang CL; Liu CH; Su YH
    Eur J Pharm Biopharm; 2008 Oct; 70(2):633-40. PubMed ID: 18577447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) -- structural investigations on two different carrier systems.
    Saupe A; Wissing SA; Lenk A; Schmidt C; Müller RH
    Biomed Mater Eng; 2005; 15(5):393-402. PubMed ID: 16179760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preparation, characterization and biodistribution of nanostructured lipid carriers for parenteral delivery of bifendate.
    Feng F; Zheng D; Zhang D; Duan C; Wang Y; Jia L; Wang F; Liu Y; Gao Q; Zhang Q
    J Microencapsul; 2011; 28(4):280-5. PubMed ID: 21545318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation and characterization of silybin-loaded nanostructured lipid carriers.
    Jia LJ; Zhang DR; Li ZY; Feng FF; Wang YC; Dai WT; Duan CX; Zhang Q
    Drug Deliv; 2010 Jan; 17(1):11-8. PubMed ID: 19941406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of process parameters on properties of Nanostructured Lipid Carriers (NLC) formulation.
    Lasoń E; Sikora E; Ogonowski J
    Acta Biochim Pol; 2013; 60(4):773-7. PubMed ID: 24432330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement.
    Muchow M; Maincent P; Müller RH; Keck CM
    Drug Dev Ind Pharm; 2011 Jan; 37(1):8-14. PubMed ID: 21138344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.